myLaurel Secures $12 Million to Further Its Acute Care at Home Program

Success of the home-based care model caught the eye of notable investors, including Deerfield Management and GV (Google Ventures). 

NEW YORK, June 3, 2025 /PRNewswire/ -- myLaurel, a rapidly growing healthcare company delivering home-based acute and transitional care, today announced it raised additional capital and held an initial closing of $12 million from existing investors. The round is led by Deerfield Management and GV, with participation from Emerson Collective, Pinta Partners, Ochsner Health, and management.

This funding follows a record-breaking 2024 and continued growth in the first quarter of 2025, marked by a 4x year-over-year increase in new patient volume and revenue. myLaurel's signature Acute Care at Home program continues to show strong clinical and financial outcomes for its hospital partners, most notably through its partnership with Ochsner. The new capital will enable the company to further expand with Ochsner and accelerate growth with new health system clients, focusing on scaling Acute Care at Home in both existing and new markets.

As the U.S. population continues to age, the demand for scalable, high-quality care outside the traditional hospital is growing rapidly. A recent report in JAMA warns that the country could face a "dangerous threshold" of hospital bed shortages by 2032, driven in large part by an aging population with increasingly complex medical needs. myLaurel's model directly addresses this challenge by enabling hospitals to deliver high-acuity care in patients' homes, improving outcomes while reducing the strain on facility throughput and capacity. 

"Our momentum reflects both the urgency of the need and the strength of our care model solution," said Juan Vallarino, CEO of myLaurel. "In partnership with systems like Ochsner, we demonstrate that high-acuity, home-based care can provide an exceptional patient experience, reduce costs, and meaningfully extend hospital capacity. This funding round validates our vision and positions us to serve more patients with greater efficiency and impact."

In 2024, myLaurel and Ochsner Health jointly developed the Acute Care at Home model, which has since outperformed expectations in clinical and operational metrics. The partnership has become a benchmark for how health systems can modernize care delivery for complex, frail, and elderly patients outside of traditional hospital walls.

"myLaurel is pioneering a scalable care model that addresses one of the most pressing challenges in healthcare — how to safely and effectively care for complex patients outside the hospital," said Moses Adubi, Principal at Deerfield. "We believe myLaurel is well-positioned to lead a transformation in acute care and deliver benefits across the continuum of care."

As the healthcare industry increasingly embraces home-based care for medically complex populations, myLaurel delivers the best of both worlds: an enhanced patient experience and improved hospital efficiency. This combination has made myLaurel a strategic partner for health systems, payers, and patients alike.

About myLaurel
myLaurel was founded on the belief that a portion of today's hospital care can—and should—be delivered in the comfort of home.  As a tech-enabled medical group, we provide on-demand acute and transitional care to frail, elderly, or medically complex patients at home—helping them avoid the traditional care path of ambulance, ER, hospital admission, and nursing facility.  

Health systems, provider groups, and payers partner with us to reduce avoidable utilization, improve readmission rates, accelerate discharges, and enhance patient experience—all while maintaining the highest standards of care and safety. We stand behind our outcomes with our partners, putting our fees at risk to demonstrate our commitment and confidence in delivering results.  

Headquartered in New York, myLaurel delivers hands-on clinical care guided by remote physicians and supported by advanced technology, diagnostics, and therapies. The result: 33% lower ED utilization, 49% fewer readmissions, 3,000+ bed days saved per hospital annually - enabling over 640 additional acute inpatient admissions -  and a patient Net Promoter Score of 96. Learn more at mylaurelhealth.com.

About Deerfield Management

Deerfield is an investment management firm committed to advancing healthcare through investment, information, and philanthropy. The Firm works across the healthcare ecosystem to connect people, capital, ideas, and technology in bold, collaborative, and inclusive ways. For more information, please visit www.deerfield.com.

About GV
GV supports innovative founders across multiple stages and sectors, from artificial intelligence and life sciences to consumer platforms, enterprise software, and frontier technology.

Launched as Google Ventures in 2009, GV oversees more than $10 billion in assets under management. Our operating partners support founding teams at every stage of company-building across executive talent, design, communications, and marketing. GV is a non-strategic venture capital firm that invests independently from its sole limited partner, Alphabet. We connect startups with Google and Alphabet companies, providing unique access to the world's best technology and talent.

GV has 400 active portfolio companies spanning North America, Europe, and Israel. Our portfolio includes Lightmatter, Stripe, Treeline Biosciences, Vercel, and Wonder, with notable exits including Uber, Nest, Slack, GitLab, Duo Security, Flatiron Health, Lemonade, and One Medical. The firm is headquartered in the San Francisco Bay Area, with offices in Cambridge, New York, and London. For more information, please visit gv.com.

For more information contact:
[email protected]

SOURCE myLaurel